CD69 and nasopharyngeal carcinoma: Impaired T cell activation was detected when T cells were incubated with macrophages that cocultured with DNA hypermethylated NPC cells induced by C1q, as indicated by a decline in CD69 expression, while comparable CD69 levels in T cells were observed when tumor cells were treated with Azacitidine (Figure 6E).